TrialArthritis research & therapy2015

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.

Sofie H M Manders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.